HKUMed team (IMAGE)

The University of Hong Kong

HKUMed team

Caption

HKUMed evaluates the safety profile and therapeutic potential of GLP-1 receptor agonists by analysing global clinical trial data comprising more than 80,000 patients with diabetes and heart disease. The research is led by Dr Will Chan Yap-hang (second right) and Professor Tse Hung-fat (middle).

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.